Aurobindo Pharma dips 5% on weak operational performance in June quarter
Aurobindo Pharma dips 5% on weak operational performance in June quarter.....»»
Tata Consumer Products declines 6% on weak operational performance in Q4
Tata Consumer Products declines 6% on weak operational performance in Q4.....»»
IndiaMART InterMESH tanks 8% on weak operational performance in March qtr
IndiaMART InterMESH tanks 8% on weak operational performance in March qtr.....»»
Puravankara Q1 results: Net profit zooms 1,024% to Rs 155 cr; sales rise 184%
Puravankara Q1 results: Net profit zooms 1,024% to Rs 155 cr; sales rise 184%.....»»
Sun Pharma rallies 9%, hits over 4-year high on strong June quarter results
Sun Pharma rallies 9%, hits over 4-year high on strong June quarter results.....»»
ACC surges 7%, hits new high on strong operational performance in Q2
ACC surges 7%, hits new high on strong operational performance in Q2.....»»
HDFC Bank dips 3% as June quarter results miss Street estimates
HDFC Bank dips 3% as June quarter results miss Street estimates.....»»
"Corporate earnings in June quarter can be weak"
"Corporate earnings in June quarter can be weak".....»»
Bandhan Bank dips 4%, hits over 6-month low on weak March quarter results
Bandhan Bank dips 4%, hits over 6-month low on weak March quarter results.....»»
DCM Shriram rallies 20% on heavy volumes, stock hit all-time high
DCM Shriram rallies 20% on heavy volumes, stock hit all-time high.....»»
Torrent Pharma rallies 9% on 1:1 bonus issue plan, dividend of Rs 23/share
Torrent Pharma rallies 9% on 1:1 bonus issue plan, dividend of Rs 23/share.....»»
OYO plans IPO post Sep, may settle for lower valuation
OYO plans IPO post Sep, may settle for lower valuation.....»»
Rupa & Company tanks 20% after disappointing Q4 performance, CEO"s exit
Rupa & Company tanks 20% after disappointing Q4 performance, CEO"s exit.....»»
Globus Spirits slips 15% on weak March quarter results
Globus Spirits slips 15% on weak March quarter results.....»»
Aurobindo Pharma says Rs 420 crore deal to acquire 51 per cent in Cronus Pharma cancelled
Aurobindo Pharma says Rs 420 crore deal to acquire 51 per cent in Cronus Pharma cancelled.....»»
As US Fed talks taper, these FPI favourite stocks could be at risk
As US Fed talks taper, these FPI favourite stocks could be at risk.....»»
FPIs" investment in domestic equity surges 7% to $592-bn in June quarter
FPIs" investment in domestic equity surges 7% to $592-bn in June quarter.....»»
Paid licence fee dues for first quarter of 2021-22: Vodafone Idea
Paid licence fee dues for first quarter of 2021-22: Vodafone Idea.....»»
April-June GDP seen "deceptively high" level of 20%: ICRA
April-June GDP seen "deceptively high" level of 20%: ICRA.....»»
Biggest gainers & losers of the day: VST Tiller and Voda on a roll; Aavas Financiers bleeds
Biggest gainers & losers of the day: VST Tiller and Voda on a roll; Aavas Financiers bleeds.....»»
GDP to expand by deceptively high 20% in Q1, to be lower than pre-COVID levels: Icra
GDP to expand by deceptively high 20% in Q1, to be lower than pre-COVID levels: Icra.....»»